DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ slipped 2.36% to $601.65 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.62% to 7,266.99 and Dow Jones Industrial Average falling 1.87% to 49,918.78.
Regeneron Pharmaceuticals Inc. closed 26.73% below its 52-week high of $821.11, which the company reached on January 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. $(AMGN)$ fell 1.98% to $337.73, Moderna Inc. (MRNA) fell 3.65% to $45.99, and Gilead Sciences Inc. (GILD) fell 3.20% to $121.48.
Trading volume (813,298) remained 123,294 below its 50-day average volume of 936,592.
Data source: Dow Jones Market Data, FactSet. Data compiled June 10, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 10, 2026 16:47 ET (20:47 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments